Edition:
United States

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.31USD
9:39am EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.31
Open
$2.31
Day's High
$2.31
Day's Low
$2.31
Volume
1,200
Avg. Vol
44,915
52-wk High
$4.54
52-wk Low
$1.43

Chart for

About

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $35.61
Shares Outstanding(Mil.): 15.41
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.50 16.04
EPS (TTM): -- -- --
ROI: -- 15.11 35.70
ROE: -- 16.59 15.40

BRIEF-Evoke Pharma reports Q3 loss per share $0.34

* Evoke Pharma reports third quarter 2017 results and highlights

Nov 14 2017

BRIEF-Evoke Pharma signs commercial agreement with Thermo Fisher Scientific

* Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​

Nov 09 2017

BRIEF-Evoke Pharma reports positive topline results from comparative exposure pharmacokinetic study for gimoti

* Evoke Pharma announces positive topline results from comparative exposure pharmacokinetic study for gimoti™

Oct 23 2017

BRIEF-Evoke pharma completes dosing for Gimoti™comparative exposure Pharmacokinetic study

* Evoke pharma completes dosing for Gimoti™ comparative exposure Pharmacokinetic study

Sep 12 2017

BRIEF-Evoke Pharma reports Q2 loss per share $0.11

* Evoke Pharma reports second quarter 2017 results and highlights

Aug 14 2017

BRIEF-Evoke pharma inc initiates comparative exposure Pharmacokinetic Study for Gimoti

* Evoke Pharma Inc - ‍initiation of its comparative exposure Pharmacokinetic trial for Gimoti​

Aug 14 2017

Competitors

Earnings vs. Estimates